Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia

被引：0
|
作者：
Becker, Pamela S.
Estey, Elihu [2 ]
Petersdorf, Stephen
Hendrie, Paul C. [1 ]
Pagel, John M. [2 ]
Stirewalt, Derek
Shustov, Andrei
Storer, Barry E.
Appelbaum, Frederick R. [3 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Seattle, WA 98195 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1018 / 1018
页数：1
相关论文
共 50 条
  • [31] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2014, 124 (21)
  • [32] Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia
    Robak, T
    Wrzesien-Kus, A
    Lech-Maranda, E
    Kowal, M
    Dmoszynska, A
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 121 - 129
  • [33] A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia
    Griffiths, Elizabeth A.
    Brady, William E.
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Bashaw, Heather L.
    Sperrazza, Jill
    Wetzler, Meir
    Wang, Eunice S.
    LEUKEMIA RESEARCH, 2016, 43 : 44 - 48
  • [34] A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
    David Martínez-Cuadrón
    Blanca Boluda
    Pilar Martínez
    Juan Bergua
    Rebeca Rodríguez-Veiga
    Jordi Esteve
    Susana Vives
    Josefina Serrano
    Belen Vidriales
    Olga Salamero
    Lourdes Cordón
    Amparo Sempere
    Ana Jiménez-Ubieto
    Julio Prieto-Delgado
    Marina Díaz-Beyá
    Ana Garrido
    Celina Benavente
    José Antonio Pérez-Simón
    Federico Moscardó
    Miguel A. Sanz
    Pau Montesinos
    Annals of Hematology, 2018, 97 : 763 - 772
  • [35] High Dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-MYL) in Relapsed or Refractory AML Patients.
    Scappini, Barbara
    Gianfaldoni, Giacomo
    Salvatore, Palmieri
    Susini, Maria Chiara
    Izzo, Teresa
    Mannelli, Francesco
    Longo, Giovanni
    Fanci, Rosa
    Ferrara, Felicetto
    Bosi, Alberto
    BLOOD, 2009, 114 (22) : 438 - 438
  • [36] Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine plus cytarabine
    Knoebel, Randall W.
    McQuary, Amy
    Becker, Pamela
    Hendrie, Paul
    Petersdorf, Stephen
    Appelbaum, Frederick R.
    Estey, Eli
    LEUKEMIA RESEARCH, 2011, 35 (09) : E164 - E166
  • [37] A PHASE I TRIAL OF LENALIDOMIDE IN COMBINATION WITH INTERMEDIATE DOSE CYTARABINE (IDC) IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Vigil, E.
    Griffiths, A.
    Thompson, E.
    Brady, E.
    Dickey, M.
    Ford, A.
    Wang, S.
    Wetzler, M.
    HAEMATOLOGICA, 2012, 97 : 33 - 33
  • [38] Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
    Montillo, M
    Mirto, S
    Petti, MC
    Latagliata, R
    Magrin, S
    Pinto, A
    Zagonel, V
    Mele, G
    Tedeschi, A
    Ferrara, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (02) : 105 - 109
  • [39] A Phase I Study of Venetoclax Combined with Homoharringtonine, Cytarabine, and G-CSF for the Treatment of Pediatric De Novo Acute Myeloid Leukemia
    Cheng, Shengqin
    Gao, Li
    Wang, Yi
    Xiao, Peifang
    He, Hailong
    Lu, Jun
    Li, Jie
    Hu, Yixin
    Fan, Liyan
    Ribeiro, Raul C.
    Cheng, Cheng
    Hu, Shaoyan
    BLOOD, 2023, 142
  • [40] Efficacy and Safety of Azacytidine in Combination with Fludarabine and High-Dose Cytarabine with G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Open-Label, Phase II Study
    Al Aoun, Shaima
    Motabi, Ibraheem
    Al Ammari, Maged
    Al Ishehry, Nawal
    Marei, Mohammed
    Albtoosh, Bilal
    Tailor, Imran
    Altaf, Syed
    Zaidi, Sayid
    Alfayez, Mansour
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S284 - S284
12345